Search Results For ''

  • Tech billionaire Richard White backs Kyckr, buying 19.6% stake in tech small cap

    Highlighting the importance of compliance and transparency for investors, a corporate governance breach by agriculture company CropLogic (ASX: CLI) has landed them on the ASX watch-list which will see their announcements and activity closely scrutinised by regulators for the foreseeable future.  The situation arose following a private query from the ASX to CropLogic as to

    Read More
    Public
  • Keytone Dairy adds complementary healthfoods range with Super Cubes acquisition

    As the Australian public continues trending towards health-conscious eating, dairy producer Keytone Dairy (ASX: KTD) is expanding into the segment via the acquisition of lifestyle health and wellness brand Super Cubes.  The purchase price of $263k cash, $463k debt settlement and issue of performance-based shares will provide Keytone with Super Cubes’ products as well as

    Read More
    Public
  • Savvy investor hoards petrol ahead of US-Saudi oil tensions

    Hugh Honey is gearing up for a big payday after clearing out his local hardware store of plastic barrels and filling them with the commodity he expects to skyrocket in the coming days.  The commodity in question, petrol, is forecast to rise in price following drone attacks on a Saudi Arabian oil facility over the

    Read More
    Public
  • Looking for value in the Small Cap space

    There was a bit of a storm kicked up in the investment community recently when Michael Burry, an investor profiled in the Michael Lewis book (and subsequent film) The Big Short. Mr. Burry was famous for his bets on the American sub-prime mortgage market in anticipation of the Global Financial crisis. This time he made another

    Read More
    Public
  • Alcidion engaged by Healthscope to predict your healthcare needs

    If Doctor Google can diagnose your current ailments, medical informatics company Alcidion (ASX: ALC) may soon be predicting your future needs after being engaged by Healthscope to develop a data and analytics solution.  The agreement, valued at $895,000 over three-years, will see the two companies work together as Healthscope seeks to transform the way healthcare

    Read More
    Public
  • AdAlta partners with GE Healthcare to develop i-body diagnostic imaging

    Melbourne-based drug development company AdAlta (ASX: 1AD) has been selected by GE Healthcare, one of the world’s largest healthcare companies, to develop ‘i-bodies’ which GE can use as imaging agents.  One-tenth of the size of regular antibodies, i-bodies are a new class of human protein therapeutic which can be applied as a therapeutic drug to

    Read More
    Public